Amolyt Pharma
0 followers
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat a... Read more
Org chart
Thierry Abribat
Founder & CEO
Thierry Abribat
Collapse
Aurélie MILLERAT
Manager, Clinical Data Management
Clémentine Chalmey
Non clinical manager
Damien Aumaille
CMC Drug Product Manager
David Duracher
VP CMC
Delphine Martinez
General Counsel
Guillaume Ravel, PharmD, PhD, DABT
Director, Preclinical Development
Héloïse Boullet
Innovation Manager
Laetitia Ouafki
Director of Quality Assurance
Lou Arcudi
Chief Financial Officer
Mark Sumeray MD MS FRCS
Chief Medical Officer
Michael Culler
Chief Scientific Officer
Patrick Loustau
Chief Business Officer
Caroline Robo (Fesquet)
Director Regulatory Affairs
Soraya Allas
Senior Vice President, Clinical Development And Regulatory Affairs
Taha Ould Rouis, MD
Associate Director Clinical Development, MD
Thomas Delale
Chief Development Officer (CDO)
